Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Obstetrics and Gynecology
Volume 2017, Article ID 5175629, 5 pages
https://doi.org/10.1155/2017/5175629
Case Report

Undetected Severe Fetal Myelosuppression following Administration of High-Dose Cytarabine for Acute Myeloid Leukemia: Is More Frequent Surveillance Necessary?

Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Kansas School of Medicine, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA

Correspondence should be addressed to Jessica Parrott; ude.cmuk@3ttorrapj

Received 20 June 2017; Revised 14 August 2017; Accepted 17 August 2017; Published 17 September 2017

Academic Editor: Erich Cosmi

Copyright © 2017 Jessica Parrott and Marium Holland. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X. Thomas, “Acute myeloid leukemia in the pregnant patient,” European Journal of Haematology, vol. 95, no. 2, pp. 124–136, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Cardonick and A. Iacobucci, “Use of chemotherapy during human pregnancy,” Lancet Oncology, vol. 5, no. 5, pp. 283–291, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Ali, G. L. Jones, D. J. Culligan et al., “Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy,” British Journal of Haematology, vol. 170, no. 4, pp. 487–495, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. D. C. Doll, Q. S. Ringenberg, and J. W. Yarbro, “Managment of cancer during pregancy,” Archives of Internal Medicine, vol. 148, no. 9, pp. 2058–2064, 1988. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Chang and S. Patel, “Treatment of Acute Myeloid Leukemia During Pregnancy,” Annals of Pharmacotherapy, vol. 49, no. 1, pp. 48–68, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. D. M. Biener, G. Gossing, A. Kuehnl, M. Cremer, and J. W. Dudenhausen, “Diagnosis and treatment of maternal acute myeloid leukemia during pregnancy imitating HELLP syndrome,” Journal of Perinatal Medicine, vol. 37, no. 6, pp. 713-714, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. N. A. Murray, D. Acolet, M. Deane, J. Price, and I. A. Roberts, “Fetal marrow suppression after maternal chemotherapy for leukaemia.,” Archives of Disease in Childhood - Fetal and Neonatal Edition, vol. 71, no. 3, pp. F209–F210, 1994. View at Publisher · View at Google Scholar
  8. K. Matsuo, K. Shimoya, S. Ueda, K. Wada, M. Koyama, and Y. Murata, “Idarubicin administered during pregnancy: Its effects on the fetus,” Gynecologic and Obstetric Investigation, vol. 58, no. 4, pp. 186–188, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. M. J. Halaska, M. Komar, R. Vlk et al., “A pilot study on peak systolic velocity monitoring of fetal anemia after administration of chemotherapy during pregnancy,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 174, no. 1, pp. 76–79, 2014. View at Publisher · View at Google Scholar · View at Scopus